EIP
NVO

Ellis Investment Partners’s Novo Nordisk NVO Stock Holding History

Ellis Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,924
Closed -$202K – 241
2025
Q2 		$202K Sell
2,924
-22
-0.7% -$1.5K 0.04% 235
2025
Q1 		$205K Sell
2,946
-100
-3% -$8.26K 0.04% 224
2024
Q4 		$262K Sell
3,046
-264
-8% -$28.5K 0.05% 200
2024
Q3 		$394K Buy
3,310
+8
+0.2% +$1.07K 0.08% 162
2024
Q2 		$471K Buy
3,302
+73
+2% +$9.67K 0.1% 145
2024
Q1 		$415K Sell
3,229
-110
-3% -$13.1K 0.09% 153
2023
Q4 		$345K Sell
3,339
-262
-7% -$25.9K 0.08% 156
2023
Q3 		$327K Buy
3,601
+111
+3% +$9.78K 0.08% 156
2023
Q2 		$282K Buy
3,490
+18
+0.5% +$1.47K 0.07% 170
2023
Q1 		$276K Buy
3,472
+420
+14% +$29.8K 0.07% 169
2022
Q4 		$207K Hold
3,052
– – 0.06% 193
2022
Q3 		$152K Buy
3,052
+10
+0.3% +$536 0.04% 226
2022
Q2 		$169K Sell
3,042
-208
-6% -$11.5K 0.05% 226
2022
Q1 		$180K Hold
3,250
– – 0.04% 233
2021
Q4 		$182K Hold
3,250
– – 0.04% 241
2021
Q3 		$156K Buy
3,250
+8
+0.2% +$387 0.04% 247
2021
Q2 		$135K Buy
3,242
+24
+0.7% +$930 0.03% 267
2021
Q1 		$108K Hold
3,218
– – 0.03% 279
2020
Q4 		$112K Hold
3,218
– – 0.03% 271
2020
Q3 		$111K Buy
3,218
+14
+0.4% +$467 0.04% 251
2020
Q2 		$105K Sell
3,204
-612
-16% -$19.5K 0.04% 252
2020
Q1 		$114K Buy
3,816
+448
+13% +$13.3K 0.05% 176
2019
Q4 		$98K Hold
3,368
– – 0.03% 241
2019
Q3 		$85K Buy
3,368
+20
+0.6% +$506 0.03% 256
2019
Q2 		$86K Buy
+3,348
New +$82.7K 0.03% 254

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ellis Investment Partners's NVO Position: Q3 2025 in Review

Ellis Investment Partners sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 2,924 shares — an estimated $202K sold.

Ellis Investment Partners first reported a position in NVO in Q2 2019 and held it in 25 quarters. The position peaked at $471K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Ellis Investment Partners reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Ellis Investment Partners sold 2,924 Novo Nordisk shares in Q3 2025, an estimated $202K.
  • Ellis Investment Partners first reported a position in Novo Nordisk in Q2 2019 and held it in 25 quarters.
  • Ellis Investment Partners's Novo Nordisk position peaked at $471K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Ellis Investment Partners's 13F filing for Q3 2025, filed 22 Oct 2025.